Medical Grand Rounds

JEWISH GENERAL HOSPITAL
DEPARTMENT OF MEDICINE
MONDAY MEDICAL GRAND ROUNDS ON ZOOM

The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Medical Grand Rounds 2020-2021

1:00-2:00 PM

Join the above-mentioned Zoom Meetings by clicking on the following link:

 https://us02web.zoom.us/j/84326311701pwd=SUJhWjRtYnpsdjVwa3VwVkZaWkNEZz09Meeting ID: 843 2631 1701, Passcode: 279467
One tap mobile: +16473744685,,84326311701#,,,,,,0#,,279467# Canada
+16475580588,,84326311701#,,,,,,0#,,279467# Canada
Dial by your location:  +1 647 374 4685 Canada, +1 647 558 0588 Canada, +1 778 907 2071 Canada, +1 204 272 7920 Canada, +1 438 809 7799 Canada, +1 587 328 1099 Canada, Meeting ID: 843 2631 1701, Passcode: 279467
Find your local number:  https://us02web.zoom.us/u/kuKgSKHyb

December 14, 2020

CONVERGING PATHOMECHANISMS IN PARKINSON DISEASE AND SCHIZOPHRENIA
Hyman M. Schipper, MD, PhD, FRCPC
Professor of Neurology and Medicine, McGill University
Department of Neurosciences and Medicine (Geriatrics), Jewish General Hospital
Educational Objectives:
1. Review salient clinical and biologic features of schizophrenia and Parkinson disease (PD)
2. Review experimental data linking schizophrenia and PD to a single etiopathogenetic continuum
3. Consider potential disease-modifying interventions based on the converging pathomechanisms
Contact Person: Jeffrey Minuk, MD, Chief, Department of Neurosciences, Tel. 514-340-8222 ext. 28770.

December 7

JGH ICU EXPERIENCE OF THE COVID-19 EPIDEMIC, LESSONS LEARNED AND MORE QUESTIONS
Sandra Dial, MD, MSc
Assistant Professor of Medicine
McGill University
Critical Care Medicine
Jewish General Hospital and Montreal Chest Institute
Educational Objectives:
1. To describe the clinical characteristics of COVID-19 patients requiring critical care
2. To describe the evolution of practice changes that occurred as we gained experience
3. How can we learn from this experience
Contact Person: Paul Warshawsky, MD, Chief, Division of Adult Critical Care, Tel 514-340-7500.

November 30

THE PHOSPHATE REGULATING HORMONE FGF23: A FRIEND OR A FOE?
Andrew C. Karaplis, MD, PhD, FRCP, FACP

Professor of Medicine, McGill University
Division of Endocrinology
Director, Metabolic Bone Disease and Fracture Prevention Clinics
Jewish General Hospital
Educational Objectives:
Upon completion of this activity, participants should be able to:
1. Describe the role of bone as an endocrine organ and outline the interaction of FGF23 and other calciotropic hormones in the control of phosphate homeostasis
2. Appraise the common clinical signs of FGF23 overactivity to the underlying physiological mechanisms in bone and kidney and formulate a diagnostic approach to the patient
3. Design and execute a therapeutic plan for the patient
Contact Person: Mark Trifiro, MD, Chief, Division of Endocrinology, Tel. 514-340-8222 ext. 23976.

November 23

SOLVING POST COLONOSCOPY COLORECTAL CANCER
Linda Rabeneck, MD, MPH, FRCPC

Professor of Medicine, University of Toronto
Vice President, Prevention and Cancer Control at Ontario Health
Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES)
Toronto
Educational Objectives:
1. To learn about the risk factors for post-colonoscopy colorectal cancer
2. To understand the benefits of conducting a root cause analysis
3. To learn how to reduce the risk of post-colonoscopy colorectal cancer in practice
Contact Person: Polymnia Galiatsatos, MD, Division of Gastroenterology, Tel. 514-340-8222 x 28144.

November 16

HODGKIN LYMPHOMA: THERAPEUTIC AND MOLECULAR ADVANCES
Hans Knecht, MD

Professor of Medicine, McGill University
Division of Hematology, Jewish General Hospital
&
Nathalie Johnson, MD
Assistant Professor of Medicine, McGill University
Division of Hematology, Jewish General Hospital
Educational Objectives:
1. Risk adapted therapy and new treatment strategies
2. Deciphering the Reed-Sternberg Cells
Contact Person: Hans Knecht, MD, Chief, Division of Hematology, Tel 514-340-8222 ext. 28799.

November 9

CANADIAN PATIENT SAFETY WEEK
MEDICATION OVERLOAD: MEDSAFER AS A DEPRESCRIBING ROADMAP
Emily G. McDonald, MDCM, MSc, FRCPC

Assistant Professor of Medicine, McGill University
General Internal Medicine, McGill University Health Center
Director, Clinical Practice Assessment Unit
Director, General Internal Medicine Consult Service
Royal Victoria Hospital
Educational Objectives:
1. Discover how common polypharmacy is in older hospitalized adults
2. Learn about different tools that are available to help manage medication overload 
3. Understand why reducing harmful or unnecessary medications is a top safety priority
4. Highlight the importance of partnering with patients, their family, and the entire multidisciplinary team in discussions related to polypharmacy and medication safety
Contact Person: Chantal Bellerose, Dt. P., B. Sc., M. Sc. Health Adm., Assistant to the Directorate of Quality, Innovation, Evaluation, Performance & Clinical Ethics (DQIEPE), Coordinating Quality, Risk Management, Accreditation, Clinical Ethics User Experience & Planetree, CIUSSS CODIM, Tel. 514-340-8222 ext. 27895.

November 2

PULMONARY GENETICS: MOVING FROM THE LAB TO THE CLINIC
Benjamin Raby, MD, MPH

Leila and Irving Perlmutter Professor of Pediatrics, Harvard Medical School
Chief, Division of Pulmonary Medicine, Boston Children’s Hospital
Director, Pulmonary Genetics Center, Brigham and Women’s Hospital
Educational Objectives:
1. Learn how genetics influence a variety of common and less common respiratory diseases
2. To understand how genetic information is currently being used for the evaluation and management of patients with a wide range of respiratory diseases
3. To understand how genetic information can play a role in disease detection and early intervention in asymptomatic at-risk relatives of patients with respiratory disease
Contact Person: Carmela Pepe, MD, Division of Pulmonary Medicine, Tel. 514-340-8222 ext. 23636.

October 26, 2020

THE SUCCESS OF A DEDICATED GERIATRIC COVID UNIT AT THE JGH AND BEYOND
Elise Levinoff, MD
Assistant Professor of Medicine, McGill University
Jewish General Hospital Site Program Director Core Internal Medicine Residency at McGill University
Division of Geriatric Medicine, Jewish General Hospital
Educational Objectives:
1. To discuss and review how COVID 19 impacted frailty in geriatric patients
2. A review on the benefits of dedicated geriatric units for patients with COVID 19
3. To further implement AAPA (Approach Adapted to Senior Persons) into the acute hospital setting
Contact Person: José Morais, MD, Chief, Division of Geriatric Medicine, Tel. 514-340-7501.

October 19, 2020

SOMETIMES STEPPING BACK IS BETTER THAN A CLOSER LOOK
Jean L. Bolognia, MD
Professor of Dermatology, Yale School of Medicine
New Haven, Connecticut
Educational Objectives:
1. To appreciate the need to “step back” and have a “low power” view whenexamining the skin
2. To illustrate the concept of a “4X” clinical examination via the differential diagnosis of toxic epidermal necrolysis (TEN)
Contact Person: Robin Billick, MD, Chief, Division of Dermatology, Tel. 514-340-8222 ext. 25065.

October 12, 2020

No Rounds - Thanksgiving

October 5, 2020

Sixth Annual Department of Medicine Clinical Research Symposium
I. PULMONARY ARTERIAL RECRUITMENT AND DISTENSION AND THE ACCOMMODATION OF PULMONARY ARTERIAL FLOW IN FONTAN PATIENT
David Langleben, MD
Professor of Medicine, McGill University
Division of Cardiology, Jewish General Hospital
Educational Objectives:
1. To understand the anatomy and physiology of the Fontan repair, and its dysfunction
2. To understand the potential role of vasodilator therapy in Fontan repair
3. To understand how we assess lung perfusion to answer the above
II. CAN WE MEASURE DAMAGE IN SYSTEMIC SCLEROSIS (SSC, SCLERODERMA)?
Murray Baron, MD
Professor of Medicine, McGill University
Division of Rheumatology, Jewish General Hospital
Educational Objectives:
1. Understand the Concept of Disease Damage versus Activity
2. Learn the value of delphi exercises
3. Learn about the new SSc Damage Index
4. Appreciate the different trajectories of damage in early SSc
III. CAN A BLOOD TEST DIAGNOSIS LUNG CANCER?  
Jason Agulnik, MD
Associate Professor of Medicine, McGill University
Division of Pulmonary Medicine, Jewish General Hospital
Educational Objectives:
1. Understand work-up for advanced Non Small Cell Lung Carcinoma (NSCLC)
2. Understand the different driver mutations for NSCLC

September 28

Yom Kippur - No Rounds

September 21, 2020

NEW ENTITIES IN CANCERS (2018-2020)
Alan Spatz, MD
Professor, Departments of Pathology & Oncology, McGill University
Director, Division of Pathology, McGill University Health Center
Chief, Division of Molecular Genetics, Jewish General Hospital
Educational Objectives:
At the end of the presentation, the participants will:
1. Better understand the importance of phenotype-genotype integration in precision oncology
2. Have a better knowledge of new entities in various fields of solid and hematological cancers
3. Have a better knowledge of the technological opportunities and challenges in oncology
Contact Person:  Ms. Maureen Besley, Division of Pathology, Tel. 514-340-8274.

September 14, 2020

12:30-1:30 PM
SPECIAL EVENT: MEET AND GREET THE RESIDENTS
Elise Levinoff, MD, MSc
Assistant Professor of Medicine, McGill University
Site program Director, Core Internal Medicine Residency
Staff, Division of Geriatric Medicine, Jewish General Hospital
Contact Person: Elise Levinoff, MD, Director, Postgraduate Teaching, Tel. 514-340-8222 x 24974.

September 7, 2020

LABOUR DAY - NO ROUNDS

Page last updated on 

We always seek feedback to make our site better.